A human induced pluripotent stem cell toolbox for studying sex chromosome effects

Sex chromosomes shape male (XY)-female (XX) differences in development and disease. These differences can be modeled in vitro by comparing XY and XX human induced pluripotent stem cells (hiPSCs). However, in this system, inter-individual autosomal variation and unstable X-dosage compensation can confound identification of sex chromosomal effects. Here, we utilize sex chromosome loss in XXY fibroblasts to generate XX and XY hiPSCs that are autosomally isogenic and exhibit stable X-dosage compensation. We also create X-monosomic (XO) hiPSCs, to investigate X-Y dosage effects. Using these autosomally isogenic lines, we examine sex differences in pluripotent stem cell expression. Transcriptional differences between XX and XY hiPSCs are surprisingly modest. However, X-haploinsufficiency induces transcriptional deregulation predominantly affecting autosomes. This effect is mediated by Y-genes with broad housekeeping functions that have X-homologs escaping X inactivation. Our isogenic hiPSC lines provide a resource for exploring sex chromosome effects on development and disease in vitro.

Authors

Institutions

Publication Details

Journal
Stem Cell Reports
Published
2025-10-16
DOI
https://doi.org/10.1016/j.stemcr.2025.102678
Citations
2
Primary Topic
CRISPR and Genetic Engineering
Type
article
Field-Weighted Citation Impact
1.61
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A human induced pluripotent stem cell toolbox for studying sex chromosome effects

Ryan Hicks, Linda M. Starnes, Tania Incitti, James M. A. Turner et al.
2 citations
Stem Cell Reports
CRISPR and Genetic Engineering
1.61
article

A human induced pluripotent stem cell toolbox for studying sex chromosome effects

Ryan Hicks, Linda M. Starnes, Tania Incitti, James M. A. Turner, Jasmin Zohren, Amy Pointon, Benjamin E. Powell, Wazeer Varsally, Ruta Meleckyte, Jerry Eriksson
article en
2 citations

Abstract

Sex chromosomes shape male (XY)-female (XX) differences in development and disease. These differences can be modeled in vitro by comparing XY and XX human induced pluripotent stem cells (hiPSCs). However, in this system, inter-individual autosomal variation and unstable X-dosage compensation can confound identification of sex chromosomal effects. Here, we utilize sex chromosome loss in XXY fibroblasts to generate XX and XY hiPSCs that are autosomally isogenic and exhibit stable X-dosage compensation. We also create X-monosomic (XO) hiPSCs, to investigate X-Y dosage effects. Using these autosomally isogenic lines, we examine sex differences in pluripotent stem cell expression. Transcriptional differences between XX and XY hiPSCs are surprisingly modest. However, X-haploinsufficiency induces transcriptional deregulation predominantly affecting autosomes. This effect is mediated by Y-genes with broad housekeeping functions that have X-homologs escaping X inactivation. Our isogenic hiPSC lines provide a resource for exploring sex chromosome effects on development and disease in vitro.

Stem Cell ReportsVol. 20(11)
AstraZeneca (United Kingdom) (GB), The Francis Crick Institute (GB), AstraZeneca (South Korea) (KR), AstraZeneca (Poland) (PL), AstraZeneca (Finland) (FI)
Openalex Percentile: Top 14%
CRISPR and Genetic Engineering
1.61
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.